$RNAC
Cartesian Therapeutics, Inc.

2019 Q4 Form 10-Q Financial Statement

#000145368719000157 Filed on November 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $6.654M $0.00 $0.00
YoY Change 636.88% -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.070M $3.690M $4.060M
YoY Change -20.97% -9.11% -7.31%
% of Gross Profit
Research & Development $15.15M $8.104M $11.89M
YoY Change 47.66% -31.81% 25.05%
% of Gross Profit
Depreciation & Amortization $210.0K $200.0K $200.0K
YoY Change 10.53% 0.0% 0.0%
% of Gross Profit
Operating Expenses $19.22M $11.79M $15.94M
YoY Change 24.81% -26.01% 14.84%
Operating Profit -$11.79M -$15.94M
YoY Change -26.01% 15.06%
Interest Expense -$220.0K $388.0K $384.0K
YoY Change 46.67% 1.04% 43.28%
% of Operating Profit
Other Income/Expense, Net -$2.100M -$3.000K $3.000K
YoY Change -200.0% -118.75%
Pretax Income -$14.89M -$11.99M -$16.00M
YoY Change 1.64% -25.06% 8.99%
Income Tax
% Of Pretax Income
Net Earnings -$14.89M -$11.99M -$16.00M
YoY Change 1.62% -25.04% 9.03%
Net Earnings / Revenue -223.75%
Basic Earnings Per Share
Diluted Earnings Per Share -$284.2K -$258.3K -$714.3K
COMMON SHARES
Basic Shares Outstanding 48.20M shares 44.96M shares 22.40M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $89.90M $34.20M $50.50M
YoY Change 140.37% -32.28% -51.63%
Cash & Equivalents $89.89M $34.23M $50.49M
Short-Term Investments $0.00
Other Short-Term Assets $1.800M $1.900M $5.100M
YoY Change 2150.0% -62.75% 70.0%
Inventory
Prepaid Expenses
Receivables $5.000M
Other Receivables $0.00
Total Short-Term Assets $96.67M $36.12M $55.57M
YoY Change 129.74% -35.0% -48.24%
LONG-TERM ASSETS
Property, Plant & Equipment $1.222M $1.452M $2.109M
YoY Change -42.55% -31.15% 2.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.400M $1.400M $2.600M
YoY Change 366.67% -46.15%
Total Long-Term Assets $2.902M $3.425M $4.755M
YoY Change 20.62% -27.97% 100.55%
TOTAL ASSETS
Total Short-Term Assets $96.67M $36.12M $55.57M
Total Long-Term Assets $2.902M $3.425M $4.755M
Total Assets $99.57M $39.54M $60.32M
YoY Change 123.84% -34.45% -45.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $500.0K $1.478M $1.252M
YoY Change -54.55% 18.05% -17.58%
Accrued Expenses $13.49M $5.316M $10.22M
YoY Change 15.32% -47.97% 56.07%
Deferred Revenue $1.674M $1.023M $1.863M
YoY Change 74.56% -45.09%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $18.90M $20.90M $21.30M
YoY Change -11.68% -1.88%
Total Short-Term Liabilities $34.94M $29.48M $34.63M
YoY Change -0.57% -14.88% 205.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $0.00 $0.00 $1.800M
YoY Change -100.0% -100.0% 44.0%
Total Long-Term Liabilities $0.00 $0.00 $1.800M
YoY Change -100.0% -100.0% 44.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $34.94M $29.48M $34.63M
Total Long-Term Liabilities $0.00 $0.00 $1.800M
Total Liabilities $91.17M $44.46M $50.32M
YoY Change 82.71% -11.65% 12.71%
SHAREHOLDERS EQUITY
Retained Earnings -$335.8M -$320.9M -$263.2M
YoY Change 19.74% 21.92% 33.37%
Common Stock $9.000K $5.000K $3.000K
YoY Change 200.0% 66.67% 50.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.397M -$4.915M $7.402M
YoY Change
Total Liabilities & Shareholders Equity $99.57M $39.54M $60.32M
YoY Change 123.84% -34.45% -45.02%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income -$14.89M -$11.99M -$16.00M
YoY Change 1.62% -25.04% 9.03%
Depreciation, Depletion And Amortization $210.0K $200.0K $200.0K
YoY Change 10.53% 0.0% 0.0%
Cash From Operating Activities -$12.88M -$11.12M -$16.03M
YoY Change 1.02% -30.63% 3.82%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K $0.00 -$60.00K
YoY Change -88.89% -100.0% -50.0%
Acquisitions
YoY Change
Other Investing Activities $30.00K $11.52M $6.070M
YoY Change 89.79% -370.98%
Cash From Investing Activities -$10.00K $11.51M $6.020M
YoY Change -97.37% 91.2% -352.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 68.53M 5.030M 260.0K
YoY Change 85562.5% 1834.62% -96.46%
NET CHANGE
Cash From Operating Activities -12.88M -11.12M -16.03M
Cash From Investing Activities -10.00K 11.51M 6.020M
Cash From Financing Activities 68.53M 5.030M 260.0K
Net Change In Cash 55.64M 5.420M -9.750M
YoY Change -526.36% -155.59% -6.97%
FREE CASH FLOW
Cash From Operating Activities -$12.88M -$11.12M -$16.03M
Capital Expenditures -$40.00K $0.00 -$60.00K
Free Cash Flow -$12.84M -$11.12M -$15.97M
YoY Change 3.63% -30.37% 4.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Central Index Key
EntityCentralIndexKey
0001453687
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22471776 shares
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48196387 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22471776 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48196387 shares
CY2018Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2019Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
344000 USD
CY2019Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
37000 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37798
dei Entity Registrant Name
EntityRegistrantName
Selecta Biosciences, Inc
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1622110
dei Entity Address Address Line1
EntityAddressAddressLine1
480 Arsenal Way
dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
923-1400
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
SELB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48196387 shares
CY2019Q3 selb Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Current
CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsCurrent
34513000 USD
CY2018Q4 selb Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Current
CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsCurrent
37403000 USD
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1606000 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4673000 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
36119000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
42076000 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1452000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2127000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
594000 USD
CY2019Q3 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1379000 USD
CY2018Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
279000 USD
CY2019Q3 us-gaap Assets
Assets
39544000 USD
CY2018Q4 us-gaap Assets
Assets
44482000 USD
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1478000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1100000 USD
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5316000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11700000 USD
CY2019Q3 us-gaap Loans Payable Current
LoansPayableCurrent
20927000 USD
CY2018Q4 us-gaap Loans Payable Current
LoansPayableCurrent
21385000 USD
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
734000 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1023000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
959000 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
29478000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35144000 USD
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
34000 USD
CY2019Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
14981000 USD
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
13818000 USD
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
904000 USD
CY2019Q3 us-gaap Liabilities
Liabilities
44459000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
49900000 USD
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
5000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
3000 USD
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
320478000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
279539000 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-320865000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-280403000 USD
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4533000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4557000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-4915000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-5418000 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39544000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44482000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8104000 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11885000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27591000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37431000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3690000 USD
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4056000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12317000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13092000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
11794000 USD
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
15941000 USD
us-gaap Operating Expenses
OperatingExpenses
39908000 USD
us-gaap Operating Expenses
OperatingExpenses
50523000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11794000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-15941000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-39885000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-50523000 USD
CY2019Q3 us-gaap Investment Income Net
InvestmentIncomeNet
184000 USD
CY2018Q3 us-gaap Investment Income Net
InvestmentIncomeNet
295000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
707000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
829000 USD
CY2019Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
7000 USD
CY2018Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
26000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-33000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
97000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
388000 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
384000 USD
us-gaap Interest Expense
InterestExpense
1184000 USD
us-gaap Interest Expense
InterestExpense
1099000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000 USD
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-67000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-11994000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-16001000 USD
us-gaap Net Income Loss
NetIncomeLoss
-40462000 USD
us-gaap Net Income Loss
NetIncomeLoss
-50685000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-42000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
24000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-113000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3000 USD
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
16000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12002000 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16042000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40438000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-50782000 USD
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.71
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.94
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.27
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46407846 shares
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22403954 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43265909 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22368574 shares
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-5418000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
20000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
145000 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
30942000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1180000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
22000 USD
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-12074000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
14819000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
372000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1251000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
7000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-16394000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
56000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2019Q3 selb Stock Issued During Period Value Conversion Preferred Stock Warrants
StockIssuedDuringPeriodValueConversionPreferredStockWarrants
5715000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1303000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-11994000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-4915000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
51814000 USD
CY2018Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
1830000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
51000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1153000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
19000 USD
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-15888000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
38982000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
311000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1245000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-90000 USD
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-18796000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
21664000 USD
CY2018Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
145000 USD
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
109000 USD
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1526000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-42000 USD
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-16001000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
7402000 USD
us-gaap Net Income Loss
NetIncomeLoss
-40462000 USD
us-gaap Net Income Loss
NetIncomeLoss
-50685000 USD
us-gaap Depreciation
Depreciation
522000 USD
us-gaap Depreciation
Depreciation
789000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
154000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
101000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-67000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
85000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3734000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3924000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
338000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
354000 USD
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
1000 USD
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4078000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2816000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
378000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-369000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-13000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
810000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-7046000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1766000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38559000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-46413000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
16350000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
41655000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
18188000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
15598000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1992000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
516000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
94000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
105000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
238000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
25646000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
700000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30942000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
150000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
421000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
28000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
196000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36507000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
617000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
24000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-113000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1790000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20263000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37682000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71027000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35892000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50764000 USD
us-gaap Interest Paid Net
InterestPaidNet
1652000 USD
us-gaap Interest Paid Net
InterestPaidNet
833000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
310000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
16000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35900000 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-320900000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-280400000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s management considers many factors in selecting appropriate financial accounting policies and controls, and bases its estimates on historical experience and other market-specific or other relevant assumptions that it believes to be reasonable under the circumstances. In preparing these consolidated financial statements, management used significant estimates in the following areas, among others: revenue recognition, accounting for stock-based compensation and estimating accrued research and development expenses. The Company assesses the above estimates on an ongoing basis; however, actual results could materially differ from those estimates.</span></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34234000 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50485000 USD
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
279000 USD
CY2018Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 USD
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1379000 USD
CY2018Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
279000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35892000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50764000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentrations of Credit Risk and Off‑Balance Sheet Risk</span></div>Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, short-term deposits and investments, and accounts receivable. Cash and cash equivalents are deposited with federally insured financial institutions in the United States and may, at times, exceed federally insured limits. Management believes that the financial institutions that hold the Company’s deposits are financially credit worthy and, accordingly, minimal risk exists with respect to those balances. Generally, these deposits may be redeemed upon demand and therefore bear minimal interest rate risk. As an integral part of operating its Russian subsidiary, the Company also maintains cash in Russian bank accounts in denominations of both Russian rubles and U.S. dollars.
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11994000 USD
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16001000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-40462000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-50685000 USD
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46407846 shares
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22403954 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43265909 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22368574 shares
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.71
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.94
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.27
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5675264 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3404601 shares
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6036000 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6679000 USD
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4584000 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4552000 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1452000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2127000 USD
CY2019Q3 us-gaap Depreciation
Depreciation
200000 USD
CY2018Q3 us-gaap Depreciation
Depreciation
200000 USD
us-gaap Depreciation
Depreciation
500000 USD
us-gaap Depreciation
Depreciation
800000 USD
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1780000 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2497000 USD
CY2019Q3 selb Accrued Rent And Lease Incentive Payable Current
AccruedRentAndLeaseIncentivePayableCurrent
0 USD
CY2018Q4 selb Accrued Rent And Lease Incentive Payable Current
AccruedRentAndLeaseIncentivePayableCurrent
117000 USD
CY2019Q3 selb Accrued Collaborationand Licensing
AccruedCollaborationandLicensing
0 USD
CY2018Q4 selb Accrued Collaborationand Licensing
AccruedCollaborationandLicensing
1222000 USD
CY2019Q3 selb Accrued Patent Fees Current
AccruedPatentFeesCurrent
565000 USD
CY2018Q4 selb Accrued Patent Fees Current
AccruedPatentFeesCurrent
736000 USD
CY2019Q3 selb Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
1760000 USD
CY2018Q4 selb Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
5344000 USD
CY2019Q3 selb Accrued Audit Fees Current
AccruedAuditFeesCurrent
793000 USD
CY2018Q4 selb Accrued Audit Fees Current
AccruedAuditFeesCurrent
994000 USD
CY2019Q3 selb Accrued Grant Refund Current
AccruedGrantRefundCurrent
0 USD
CY2018Q4 selb Accrued Grant Refund Current
AccruedGrantRefundCurrent
175000 USD
CY2019Q3 us-gaap Interest Payable Current
InterestPayableCurrent
96000 USD
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
106000 USD
CY2019Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
322000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
509000 USD
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5316000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11700000 USD
CY2019Q1 selb Operating Lease Remaining Lease Term
OperatingLeaseRemainingLeaseTerm
P15M
CY2019Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.100
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
500000 USD
CY2018Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
500000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
1500000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
1500000 USD
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
341000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
1023000 USD
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
211000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
625000 USD
CY2019Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
3000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
14000 USD
CY2019Q3 us-gaap Lease Cost
LeaseCost
555000 USD
us-gaap Lease Cost
LeaseCost
1662000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
374000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
375000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
749000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
15000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
734000 USD
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
734000 USD
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
734000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1108000 USD
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0M15D
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10
selb Debt Instrument Event Of Default Minimum Assets Trigger
DebtInstrumentEventOfDefaultMinimumAssetsTrigger
300000 USD
selb Debt Instrument Event Of Default Minimum Amount In Excess Of Indebtedness Trigger
DebtInstrumentEventOfDefaultMinimumAmountInExcessOfIndebtednessTrigger
300000 USD
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
30900000 USD
CY2016Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
64500000 USD
CY2016Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
10126118 shares
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
48196387 shares
CY2019Q3 selb Votes Per Shareof Common Stock
VotesPerShareofCommonStock
1 vote
us-gaap Dividends Common Stock
DividendsCommonStock
0 USD
CY2019Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8882306 shares
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5951523 shares
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1303000 USD
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1485000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3734000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3924000 USD
CY2016Q4 selb License And Option Agreement Number Of Additional Targets For Which Other Party May Exercise Options For Additional Licenses
LicenseAndOptionAgreementNumberOfAdditionalTargetsForWhichOtherPartyMayExerciseOptionsForAdditionalLicenses
4 target
CY2019Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
9300000 USD
CY2019Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.088
CY2019Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2018Q4 selb Contractwith Customer Liability Deferred Revenue
ContractwithCustomerLiabilityDeferredRevenue
14777000 USD
CY2019Q3 selb Contractwith Customer Liability Deferred Revenue
ContractwithCustomerLiabilityDeferredRevenue
16004000 USD
selb Contractwith Customer Liability Increase From Cash Receipts
ContractwithCustomerLiabilityIncreaseFromCashReceipts
1250000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2149000 USD
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
16004000 USD
CY2018Q4 selb Contractwith Customer Liability Other
ContractwithCustomerLiabilityOther
2126000 USD
selb Contractwith Customer Liability Deferred Revenue Increase From Cash Receipts
ContractwithCustomerLiabilityDeferredRevenueIncreaseFromCashReceipts
1250000 USD
selb Contractwith Customer Liability Deferred Revenue Revenue Recognized
ContractwithCustomerLiabilityDeferredRevenueRevenueRecognized
23000 USD
selb Contractwith Customer Liability Other Increase From Cash Receipts
ContractwithCustomerLiabilityOtherIncreaseFromCashReceipts
0 USD
selb Contractwith Customer Liability Other Revenue Recognized
ContractwithCustomerLiabilityOtherRevenueRecognized
2126000 USD
CY2019Q3 selb Contractwith Customer Liability Other
ContractwithCustomerLiabilityOther
0 USD
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
16903000 USD
CY2019Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
selb Defined Contribution Plan Employers Matching Contribution Vesting Period
DefinedContributionPlanEmployersMatchingContributionVestingPeriod
P4Y
CY2019Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 USD
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 USD
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
200000 USD

Files In Submission

Name View Source Status
0001453687-19-000157-index-headers.html Edgar Link pending
0001453687-19-000157-index.html Edgar Link pending
0001453687-19-000157.txt Edgar Link pending
0001453687-19-000157-xbrl.zip Edgar Link pending
exhibit101cfoemploymen.htm Edgar Link pending
exhibit102feasibilitys.htm Edgar Link pending
exhibit103leaseagreeme.htm Edgar Link pending
exhibit31109302019.htm Edgar Link pending
exhibit31209302019.htm Edgar Link pending
exhibit32109302019.htm Edgar Link pending
exhibit32209302019.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
selb-20190930.xsd Edgar Link pending
selb-20190930_cal.xml Edgar Link unprocessable
selb-20190930_def.xml Edgar Link unprocessable
selb-20190930_lab.xml Edgar Link unprocessable
selb-20190930_pre.xml Edgar Link unprocessable
selectabiosciences10-q.htm Edgar Link pending
selectabiosciences10-q_htm.xml Edgar Link completed
Show.js Edgar Link pending